Ibandronate sodium

CAS No. 138844-81-2

Ibandronate sodium( —— )

Catalog No. M11612 CAS No. 138844-81-2

Ibandronate Sodium is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 34 In Stock
10MG 46 In Stock
25MG 72 In Stock
50MG 91 In Stock
100MG 117 In Stock
200MG Get Quote In Stock
500MG 294 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ibandronate sodium
  • Note
    Research use only, not for human use.
  • Brief Description
    Ibandronate Sodium is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
  • Description
    Ibandronate Sodium is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HBV
  • Recptor
    HAP| FPS
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    138844-81-2
  • Formula Weight
    341.21
  • Molecular Formula
    C9H22NNaO7P2
  • Purity
    >98% (HPLC)
  • Solubility
    Free soluble in Water
  • SMILES
    O.[Na+].[Na+].CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)([O-])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dunford JE, et al. J Pharmacol Exp Ther. 2001 Feb; 296(2):235-42.
molnova catalog
related products
  • GLS4

    GLS4 (Morphothiadin) is a potent inhibitor of HBV capsid assembly, inhibits HBV replication (EC50=62.24 nM) and reduces HBV-DNA levels in HepG.2.2.15 cells (IC50=14 nM).

  • Linvencorvir

    Linvencorvir is a hepatitis B virus (HBV) core protein variant modifier used to treat chronic HBV infection.

  • Besifovir

    Besifovir (PMCDG Dipivoxil, NA-380, LB-80380) is a potent, selective, orally available anti-HBV agent, the prodrug of PMCDG (EC50=4 uM).